Oncology R&D trends and breakthrough innovations
Explore the latest in oncology R&D with Inpart’s new trends report, featuring emerging technologies, breakthrough innovations, and expert insights shaping the future of cancer research.
Cancer
- Latest Posts
Best in Biotech 16 May 2025
Nine promising small molecule drug discovery companies to look out for in 2025
Discover nine small molecule drug discovery companies that have raised funding for their novel medicines in the last year.
Best in Biotech 13 May 2025
Nine biotech companies in Montreal to keep an eye on in 2025
Discover nine of the hottest biotech companies in Montreal that are advancing preclinical and clinical research.
In Depth 7 May 2025
Unlocking immunity: the power of TLR agonists
Let us delve into some of the TLR agonists in the clinic and why the careful selection of these drugs is crucial.
News and Trends 7 May 2025
Top biotech deals of April 2025
Learn about April 2025’s top biotech deals, featuring major collaborations in bispecific antibodies, protein therapies, and drug delivery.
In Depth 2 May 2025
From pandemic spotlight to post-COVID crossroads: What happened to these biotech players?
Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article.
ADVERTISEMENT
ADVERTISEMENT
Podcast 2 May 2025
TCR-NK: A novel cell therapy transforming cancer treatment
Are TCR-NK treatments the next big thing in cell therapies for cancer patients? Find out in our talk with Namir Hassan, CEO of Zelluna.
In Depth 30 Apr 2025
The future of NSCLC treatment: what’s in store for the therapeutic space?
Here we delve into the different kinds of NSCLC therapies in the running to potentially address late-stage cancer that is often difficult to treat.
News and Trends 2 Apr 2025
Top biotech deals of March 2025
Learn about the top biotech deals of March 2025. Small molecules, bispecific antibodies, and protein therapies were all part of major collaborations.
In Depth 26 Mar 2025
A guide to kinase inhibitors in biotech: From cancer breakthroughs to autoimmune innovations
Delve into the kinase inhibitors’ diverse landscape, from cancer breakthroughs to autoimmune disease innovations.
News and Trends 24 Mar 2025
First-ever RIPTAC enters clinic: all you need to know about this new cancer approach
The first RIPTAC has just hit the clinic. Learn about this new technology that is being developed by Halda Therapeutics.
Best in Biotech 18 Mar 2025
Cancer vaccines: 11 biotechs to keep an eye out for
As various biotechs across the world specialize in the production of cancer vaccines, here are 11 companies making progress in the field.
ADVERTISEMENT
